红蝶butterfly品牌怎么样 申请店铺

我要投票 红蝶butterfly在办公设备行业中的票数:667 更新时间:2025-12-22
红蝶butterfly是哪个国家的品牌?「红蝶butterfly」是红蝶科技(深圳)有限公司旗下著名品牌。该品牌发源于广东省深圳市,由创始人那庆林在2008-05-21期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力红蝶butterfly品牌出海!将品牌入驻外推网,定制红蝶butterfly品牌推广信息,可以显著提高红蝶butterfly产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

红蝶butterfly怎么样

红蝶科技(深圳)有限公司(简称红蝶),是世界上一家推出新电子消费品概念——智能投影电脑的企业,是拥有自主知识产权的技术企业。红蝶是全球较早研发微显示技术光学引擎公司之一,也是显示技术行业的重要企业。

经过近6年的积累和沉淀,红蝶攻克技术难关,推出行业领域电子产品革命的产品,成为智能投影技术的佼佼者。红蝶发明的智能投影技术,推动行业潮流。基于此项技术的新产品——互动式微投影电脑给用户带来新体验。手机大小尺寸的产品,瞬间给你提供一个六十寸或更大的高清屏幕可以在身旁,面前或者头顶显示出高清画面的平板电脑界面。智能的自动技术连基本的调焦动作都予以取消。基于红蝶专利技术的遥控笔设计简单,拥有良好的手感,可以提供灵敏迅速的人机交互。他将会带您进入新的空间,亦幻亦真的体感体验,在目前种类众多的消费电子产品中独树一帜,脱颖而出。此项技术应用于手机、平板电脑、和智能电视领域,将掀起一股新的技术革命。

红蝶在成立之初就确定了以研发为导向的成长路线并保持至今。以研发为导向,意味着以研发和知识产权为核心竞争力意味着在深厚技术积累基础上的厚积薄发,更意味着对创新的执着追求。因为公司相信, 创新 才是发展的真正原动力。经过近6年的艰苦研发,公司突破了围绕 智能投影 的大量核心技术。除智能投影的光学和软件技术,公司还在配套的光源技术,光器件技术和结构件技术方面积累了大量经验和知识产权。红蝶拥有智能投影技术的全部核心知识产权并将该产品专利池覆盖中国、美国、欧盟、日本、韩国等世界多个国家。借助技术、产品、知识产权的优势,红蝶成为智能投影行业的全球企业。

红蝶的基本业务包括智能投影电脑产品,投影光学引擎,和配套光源的研发制造。公司的业务范围目前涵盖消费电子产品的民用和商用两方面,同时公司的投影和光源技术也在舞台灯光等行业广受欢迎。红蝶以不断创新为发展战略,努力推出创新产品,为客户提供优良解决方案;持续投入基础光学、光源技术,软件开发和精密结构等前沿技术,努力成为以光、机、电技术为核心基础的持续发展高科技企业。


Hongdie Technology (Shenzhen) Co., Ltd. (hereinafter referred to as hongdie) is an enterprise in the world that has launched a new concept of electronic consumer goods - Intelligent projection computer, and a technology enterprise with independent intellectual property rights. Hongdie is one of the earliest companies to develop micro display technology optical engine in the world, and also an important enterprise in display technology industry. After nearly six years of accumulation and precipitation, red butterfly has overcome the technical difficulties, launched the electronic product revolution products in the industry, and become the leader of intelligent projection technology. The intelligent projection technology invented by hongdie promotes the trend of the industry. The interactive micro projection computer, a new product based on this technology, brings new experience to users. Mobile phone size products provide you with a 60 inch or larger high-definition screen in an instant, which can display a high-definition screen in front of you or in front of you. The intelligent automatic technology even cancels the basic focusing action. The remote control pen based on red butterfly patented technology is simple in design, has good hand feeling, and can provide sensitive and rapid human-computer interaction. He will take you into a new space, and also experience the illusion and the real sense of body. He will be unique and stand out in the current variety of consumer electronics products. The application of this technology in mobile phones, tablet computers and smart TV will set off a new technological revolution. At the beginning of its establishment, red butterfly established a R & D-oriented growth path and has remained so far. Taking R & D as the guide means taking R & D and intellectual property as the core competitiveness, which means accumulating and developing on the basis of deep technology accumulation, and also means persistent pursuit of innovation. Because the company believes that innovation is the real driving force of development. After nearly six years of hard research and development, the company has broken through a large number of core technologies around intelligent projection. In addition to the optical and software technology of intelligent projection, the company has also accumulated a lot of experience and intellectual property rights in supporting light source technology, optical device technology and structure technology. Hongdie owns all the core intellectual property rights of intelligent projection technology and covers the patent pool of this product in China, the United States, the European Union, Japan, South Korea and other countries in the world. With the advantages of technology, products and intellectual property rights, hongdie has become a global enterprise in the intelligent projection industry. Hongdie's basic business includes the R & D and manufacturing of intelligent projection computer products, projection optical engines and supporting light sources. At present, the company's business scope covers both civil and commercial aspects of consumer electronic products. At the same time, the company's projection and light source technology are also popular in stage lighting and other industries. Hongdie takes continuous innovation as its development strategy, strives to launch innovative products and provide customers with excellent solutions; continues to invest in cutting-edge technologies such as basic optics, light source technology, software development and precision structure, and strives to become a high-tech enterprise with continuous development based on optical, mechanical and electrical technologies.

本文链接: https://brand.waitui.com/05adafcb7.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

科力尔:全资孙公司终止与瑞业数金的战略合作协议

36氪获悉,科力尔公告,由于客观原因导致合伙企业基金设立条件发生变化,且受市场环境变化、合作双方及相关意向方实际情况调整等多种因素影响,公司全资孙公司深圳市鹏睿投资发展有限公司与深圳市瑞业数金私募股权基金管理有限公司决定终止《战略合作协议》。截至公告披露日,双方尚未签署任何正式合作协议或其他具备实质约束力的法律文件,亦未实际进行出资。该事项不会对公司日常经营及财务状况造成重大实质性影响。

2小时前

观想科技:筹划购买辽晶电子不低于60%股权,股票明起停牌

36氪获悉,观想科技公告,公司正在筹划发行股份购买锦州辽晶电子科技股份有限公司公司(简称“辽晶电子”)不低于60%的股权并募集配套资金事项,辽晶电子经营范围包括集成电路、电力、电子元器件的设计、生产、销售等。因有关事项尚存不确定性,为了维护投资者利益,避免对公司证券交易造成重大影响,公司股票自2025年12月22日起开始停牌。预计在不超过10个交易日的时间内披露本次交易方案。若公司未能在上述期限内召开董事会审议并披露交易方案,公司证券最晚将于2026年1月7日开市起复牌并终止筹划相关事项。

2小时前

*ST名家:资本公积金转增股本实施完成,股票复牌

36氪获悉,*ST名家公告,公司资本公积金转增股本已全部完成,共计转增7.3亿股,总股本增至14.26亿股。其中,重整投资人受让6.64亿股为首发后限售股,债权人受让6600万股为无限售条件流通股。公司股票将于12月22日开市起复牌,复牌后调整后的除权参考价格为3.16元/股。

2小时前

中信证券:推动人民币升值的因素逐渐增多,可关注三条线索

36氪获悉,中信证券研究指出,推动人民币升值的因素逐渐增多,市场关注度也开始升温,投资者要逐步适应在一个人民币持续升值的环境下去做资产配置。从过去20年间7轮人民币升值周期来看,汇率并不是主导行业配置的决定性因素。然而,部分行业在持续升值预期形成的初期确实会有更好表现,市场可能会复制这样的肌肉记忆,同时从成本收入分析来看,约19%的行业会因为升值带来利润率提升,这些行业也会逐步被投资者重视起来。此外,为抑制过快单边升值趋势而做出的政策应对,反而是影响行业配置的更重要因素。

2小时前

健康元:控股子公司获得NS-041片新增抑郁症临床试验批准通知书

36氪获悉,健康元公告,公司控股子公司丽珠制药厂收到国家药品监督管理局核准签发的关于NS-041片新增针对“治疗抑郁症”适应症的《药物临床试验批准通知书》。NS-041片是一款新型高选择性KCNQ2/3激动剂,目标用于癫痫和抑郁症等神经精神类疾病的治疗,系目前国内唯一获批同时开展癫痫和抑郁症临床研究的KCNQ2/3 靶向药物。但需注意,药物在获得临床试验批准通知书后,尚需开展临床试验并经国家药监局审评、审批通过后方可生产上市,存在诸多不确定性。

2小时前

本页详细列出关于红蝶butterfly的品牌信息,含品牌所属公司介绍,红蝶butterfly所处行业的品牌地位及优势。
咨询